orchardvc.com
Orchard Venture Partners - Portfolio
http://www.orchardvc.com/portfolio.html
Orchard. Venture partners. Portfolio Founding • Funding. Assets • Innovation. Akebia Therapeutics www.akebia.com. Novartis Venture Fund, Triathlon Medical Ventures, Venture Investors, Kearny Venture Partners. Aerpio Therapeutics www.aerpio.com. Nymirum www.nymirum.com. Nymirum is a drug discovery company with a proprietary platform that targets RNA with small molecules. Drug developers around the world have focused on RNA as one of the most promising new areas of the 21st century. Utilizing small...ProNA...
tmvp.com
Triathlon Medical Ventures - TMVP.com
http://www.tmvp.com/Portfolio.html
AERPIO THERAPEUTICS, INC. AKEBIA THERAPEUTICS, INC. CoLUCID PHARMACEUTICALS, INC. SIRONRX THERAPEUTICS, INC. TOLERA THERAPEUTICS, INC. EXPANDING ORTHOPEDICS, INC. LONESTAR HEART, INC. REMON MEDICAL TECHNOLOGIES, INC. RENAL SOLUTIONS, INC. AERPIO THERAPEUTICS, INC. 10151 Carver Road, Suite 205. Cincinnati, OH 45242-4760. Aerpio Therapeutics is a new, clinical-stage biotechnology company focused on the development of novel small molecules and monoclonal antibodies for the treatment of vascular disease and ...
cincytechusa.com
Portfolio – CincyTech
http://cincytechusa.com/about/portfolio
CincyTech is a public-private seed-stage investor whose mission is to be a trusted partner in helping to transform ideas into high potential technology companies in Southwest Ohio. 1311 Vine Street, Suite 300. Cincinnati, OH 45202.
burnsmcclellan.com
Healthcare Clients - Burns McClellan
http://burnsmcclellan.com/clients
Investor and Public Relations for Life Sciences Organizations. 257 Park Avenue South, 15th Flr., New York, NY. 212) 213.0006 info@burnsmc.com. Our Partners in Europe. 1 Fetter Ln, London EC4A 1BR, United Kingdom. Weill Cornell Medical College. Foundation for Prader Willi Research. Web Design by Second Language.
diabetesnewsjournal.com
Aerpio Therapeutics Announces Positive Data of TIME-2 trial of AKB-9778 in Diabetic Macular Edema
http://diabetesnewsjournal.com/2015/07/21/aerpio-therapeutics-announces-positive-data-of-time-2-trial-of-akb-9778-in-diabetic-macular-edema
This is a short description about myself and what this site is about. I hope you enjoy being here! My Type 1 Diabetes Journey. Bariatric Surgery And Diabetes. Aerpio Therapeutics Announces Positive Data of TIME-2 trial of AKB-9778 in Diabetic Macular Edema. July 21, 2015. July 27, 2015. By Daniela Semedo, PhD. Type 2 Diabetes News. For patients with Diabetes Mellitus Edema. Results from the safety analysis showed no clinical differences between the three study arms in terms of ocular or non-ocular advers...
nizetlab.ucsd.edu
Nizet Lab: Scientific Collaborations
http://nizetlab.ucsd.edu/Collaborations
COLLABORATIONS HERE AT UCSD. Richard Gallo, MD, PhD. Professor of Medicine and Pediatrics. Chief, Division of Dermatology. Skin Innate Immunity, Cathelicidin Antimicrobial Peptides. Ajit Varki, MD. Distinguished Professor of Medicine and Cellular and Molecular Medicine. Sialic Acids and Siglecs in Bacterial Host-Pathogen Interactions. Michael Karin, PhD. Distinguished Professor of Pharmacology. Innate Immunity, NF k. B/IKK and Inflammasome Signaling. Partho Ghosh, PhD. Pieter Dorrestein, PhD. Development...
danforthadvisors.com
Danforth Advisors :: Who We Serve
http://www.danforthadvisors.com/whoweserve.html
Integrated Business Solutions for Life Science. And Renewable Energy Companies. Danforth Advisors works with CEOs, entrepreneurs, and investors in the following sectors:. Is a specialty pharmaceutical company primarily focused on the development of cardiovascular drugs for the detection of coronary artery disease. San Mateo, CA. Is a clinical stage biopharmaceutical company with a mission to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. Algeta ASA is focused on dev...
ventureinvestors.com
Portfolio Companies – Venture Investors
http://www.ventureinvestors.com/portfolio-companies
Feature some of the leading technology innovators in the Midwest. We are proud to work closely with our technical founders and executive teams as they bring their technologies to market. Cellectar Biosciences, Inc. Aerpio Therapeutics is a pharmaceutical company spun out of Akebia Therapeutics, with programs focused on Tie2 activation for the treatment of retinopathy, vascular leak, cancer, inflammatory bowel disease and would healing. Cellectar Biosciences, Inc. Elucent Medical is a medical device compa...
